NASD

Vincera Pharma, Inc. (VINC)

LAST (2 Apr, 2:19 PM ET)
0.6425
+0.0675  (+11.74%)
Extended HOURS (00:00 PM ET)
-
-  (+000.00%)
MARKET CAP
1.202 M
VOLUME
734,374
ENTER A SYMBOL
MEMBER ACTIONS
Summary as of: 2 Apr, 2:19 PM ET
Open 0.56
Previous Close 0.575
Day Range 0.54 - 0.65
52-Week Range 0.48 - 136.80
All-Time High 535.00
Avg. Volume (50-day) 1,192,310.9
EPS (TTM) -19.5628
Next Earnings Date 2025-05-13 (AMC)
Last Earnings Date 2025-03-27
Forward Annual Dividend (Yield) -
Trailing Annual Dividend (Yield) -
Options No
Fundamentals
P/E Ratio -0.0300
PEG Ratio -
Price to Book 0.47
Price to Cash Flow -
Price to Free Cash Flow -
Total Sales (TTM) -
Revenue per Share (TTM) -
Shares Outstanding 2.240 M
Share Float (%) 1.92 M (85.75%)
% Held by Institutions 10.71
Dividends Per Share (TTM) -
Ex-Dividend Date -
Technicals
+/- EMA(20) 0.72 (-10.76%)
+/- SMA(50) 1.12 (-42.63%)
+/- SMA(200) 7.63 (-91.58%)
5-Day Perf. +6.62%
1-Month Perf. -41.06%
3-Month Perf. -86.35%
6-Month Perf. -95.37%
YTD Perf. -87.78%
1-Year Perf. -99.5%
RSI(14) 35.33
ATR(14) 0.13
ADX(14) 13.46
Beta (5Y) -
Earnings NEW

FOR STOCKCHARTS MEMBERS ONLY

Unlock earnings and revenue history when you join StockCharts

As a StockCharts Member, you can review earnings results and analyze revenue and earnings growth over time. Bring a balance of technicals and fundamentals to your approach when you join today!

SCTR Rank SCTR Reports  

VINC

1.7
(-0.1)
SCTR Universe: Small Cap
Click Here for more info about the StockCharts Technical Rankings (SCTRs)
Profile

Vincera Pharma, Inc.

260 Sheridan Avenue, Suite 400
Palo Alto, California
http://vincerx.com
Sector: -
Industry: -
Employees: 13
Description

Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company which develops antibody drugs. It focuses on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The firm pipeline is derived from a license agreement with Bayer and includes: a clinical-stage and follow-on small molecule drug program and preclinical stage bioconjugation/next-generation antibody-drug conjugate platform. The company was founded by Ahmed M. Hamdy, Raquel E. Izumi, Tom C. Thomas, Soo In Hwang and John C. Byrd on December 19, 2018 and is headquartered in Palo Alto, CA.

Predefined Scans with VINC View All  
Alerts for VINC View All   New

FOR STOCKCHARTS MEMBERS ONLY

Unlock custom technical alerts when you join StockCharts

As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.

ChartLists with VINC

FOR STOCKCHARTS MEMBERS ONLY

Unlock ChartLists to save and organize your charts when you join StockCharts

As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.